AUTL
Autolus Therapeutics Plc
$3.8
Earnings Summary
Revenue | $1.78Mn |
Net Profits | $-77.17Mn |
Net Profit Margins | -4347.66% |
Highlights
Autolus Therapeutics Plc’s revenue fell -53.59% since last year same period to $1.78Mn in the Q4 2023. On a quarterly growth basis, Autolus Therapeutics Plc has generated 337.19% jump in its revenue since last 3-months.
Autolus Therapeutics Plc’s net profit fell -186.34% since last year same period to $-77.17Mn in the Q4 2023. On a quarterly growth basis, Autolus Therapeutics Plc has generated -68.32% fall in its net profits since last 3-months.
Autolus Therapeutics Plc’s net profit margin fell -517.04% since last year same period to -4347.66% in the Q4 2023. On a quarterly growth basis, Autolus Therapeutics Plc has generated 61.5% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Autolus Therapeutics Plc post its latest quarter earnings
EPS Estimate Current Quarter | -0.05 |
EPS Estimate Current Year | -0.05 |
Highlights
Autolus Therapeutics Plc’s earning per share (EPS) estimates for the current quarter stand at -0.05 - a 80% jump from last quarter’s estimates.
Autolus Therapeutics Plc’s earning per share (EPS) estimates for the current year stand at -0.05.
Key Ratios
Key ratios of the Autolus Therapeutics Plc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.45 |
Highlights
Autolus Therapeutics Plc’s earning per share (EPS) fell -95.65% since last year same period to -0.45 in the Q4 2023. This indicates that the Autolus Therapeutics Plc has generated -95.65% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-03 | -0.22 | -0.26 | -18.18% |
2023-11-02 | -0.25 | -0.26 | -4% |
2023-05-04 | -0.27 | -0.23 | 14.81% |
2024-03-21 | -0.25 | -0.45 | -80% |
₹0 US Stocks a/c Opening Fee